Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Government Resource

New dosing recommendations to prevent potential Valcyte (valganciclovir) overdose in pediatric transplant patients.

New dosing recommendations to prevent potential Valcyte (valganciclovir) overdose in pediatric transplant patients. United States Food and Drug Administration; FDA.

Save
Print
September 29, 2010
United States Food and Drug Administration; FDA.
This announcement describes revised dosing recommendations designed to prevent overdosing immunocompromised pediatric patients.
Save
Print
Cite
Citation

New dosing recommendations to prevent potential Valcyte (valganciclovir) overdose in pediatric transplant patients. United States Food and Drug Administration; FDA.